Keyword: experimental drugs
News
13.02.2024
-
US biopharmaceutical company Gilead Sciences is to acquire CymaBay Therapeutics for $4.3 billion. Gilead offered to purchase all outstanding shares of CymaBay for $32.50...
News
07.02.2013
- Seven European drugmakers are to pool their research efforts with academic scientists and smaller companies in a new €196 million ($265 million) project designed to find tomorrow's...